Acasti Appoints Seasoned Executive Brian D. Ford CPA-CA as Chief Financial OfficerGlobeNewsWire • 09/16/20
Acasti Announces Filing and Mailing of Information Circular and Change in Record DateGlobeNewsWire • 09/11/20
Acasti Pharma Reports Topline Triglyceride Results from Phase 3 TRILOGY 2 Study of CaPre in Patients with Severe HypertriglyceridemiaGlobeNewsWire • 08/31/20
Acasti Pharma Submits Statistical Analysis Plan to FDA and Remains On Track to Report TRILOGY 2 Topline Data On or About August 31, 2020GlobeNewsWire • 07/31/20
Acasti Pharma Inc. (ACST) CEO Jan D'Alvise on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 06/30/20
Acasti Pharma Awarded Notice of Allowance for Second Composition of Matter Patent in CanadaGlobeNewsWire • 04/20/20
Acasti Pharma Submits FDA Meeting Request on Schedule, and FDA Meeting Expected in the Second Half of JuneGlobeNewsWire • 04/01/20
Acasti Pharma Inc. (ACST) CEO Jan D'Alvise on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/14/20
Acasti Pharma Provides Update on TRILOGY 1 and TRILOGY 2 Phase 3 Trials of CaPreGlobeNewsWire • 02/10/20